Education
About Us
Working with TipRanks
Follow Us
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
Total Valuation
Boundless Bio Inc. has a market cap or net worth of $28.21M. The enterprise value is -$40.28M.
Market Cap$28.21M
Enterprise Value-$40.28M
Share Statistics
Boundless Bio Inc. has 22,385,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,385,610
Owned by Insiders8.20%
Owned by Institutions15.93%
Financial Efficiency
Boundless Bio Inc.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -36.95%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-36.95%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count64
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Boundless Bio Inc. is ―. Boundless Bio Inc.’s PEG ratio is -0.01.
PE Ratio―
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.33
Price to FCF-0.78
Price to Operating Cash Flow-0.50
PEG Ratio-0.01
Income Statement
In the last 12 months, Boundless Bio Inc. had revenue of 0.00 and earned -65.36M in profits. Earnings per share was -3.85.
Revenue0.00
Gross Profit-1.09M
Operating Income-73.27M
Pretax Income-65.36M
Net Income-65.36M
EBITDA-64.28M
Earnings Per Share (EPS)-3.85
Cash Flow
In the last 12 months, operating cash flow was -52.12M and capital expenditures -588.00K, giving a free cash flow of -52.70M billion.
Operating Cash Flow-52.12M
Free Cash Flow-52.70M
Free Cash Flow per Share-2.35
Dividends & Yields
Boundless Bio Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.91
52-Week Price Change-65.64%
50-Day Moving Average1.26
200-Day Moving Average1.41
Relative Strength Index (RSI)39.05
Average Volume (3m)166.93K
Important Dates
Boundless Bio Inc. upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Boundless Bio Inc. as a current ratio of 18.98, with Debt / Equity ratio of 40.35%
Current Ratio18.98
Quick Ratio18.98
Debt to Market Cap0.00
Net Debt to EBITDA-0.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Boundless Bio Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Boundless Bio Inc. EV to EBITDA ratio is -1.09, with an EV/FCF ratio of -1.11.
EV to Sales0.00
EV to EBITDA-1.09
EV to Free Cash Flow-1.11
EV to Operating Cash Flow-1.16
Balance Sheet
Boundless Bio Inc. has $117.57M in cash and marketable securities with $49.76M in debt, giving a net cash position of $67.81M billion.
Cash & Marketable Securities$117.57M
Total Debt$49.76M
Net Cash$67.81M
Net Cash Per Share$3.03
Tangible Book Value Per Share$8.87
Margins
Gross margin is -34.85%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-34.85%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Boundless Bio Inc. is $3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.50
Price Target Upside184.55% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast-0.50%